{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:17:32Z","timestamp":1793776652875,"version":"4.6.1"},"reference-count":310,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","award":["0224C004"],"award-info":[{"award-number":["0224C004"]}],"id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","award":["0224C029"],"award-info":[{"award-number":["0224C029"]}],"id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","award":["0224C027"],"award-info":[{"award-number":["0224C027"]}],"id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301104"],"award-info":[{"award-number":["82301104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20230160"],"award-info":[{"award-number":["BK20230160"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["2019060009"],"award-info":[{"award-number":["2019060009"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jconrel.2025.113984","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:22:52Z","timestamp":1751358172000},"page":"113984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["In situ antigen-capture strategies for enhancing dendritic cell-mediated anti-tumor immunity"],"prefix":"10.1016","volume":"385","author":[{"given":"Jingben","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbin","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113984_bb0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4(+) T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s40820-021-00761-w","article-title":"A MXene-based bionic cascaded-enzyme nanoreactor for tumor phototherapy\/enzyme dynamic therapy and hypoxia-activated chemotherapy","volume":"14","author":"Zhang","year":"2021","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.jconrel.2025.113984_bb0030","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.7150\/thno.56482","article-title":"Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view","volume":"11","author":"Huang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.113984_bb0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7150\/thno.67300","article-title":"Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy","volume":"12","author":"Ji","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.113984_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211130","article-title":"Harnessing nanomaterials for Cancer Sonodynamic immunotherapy","volume":"35","author":"Liang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102751","article-title":"Toxicity of immunotherapy combinations with chemotherapy across tumor indications: current knowledge and practical recommendations","volume":"127","author":"Rached","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2021.10.003","article-title":"Radiotherapy and immunotherapy: open questions and future strategies","volume":"8","author":"Pointer","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2023.100022","article-title":"Advancements in modifying the efficacy of immunotherapies through the thermal effects of nanomaterials","volume":"2","author":"Lei","year":"2023","journal-title":"Nano TransMed."},{"key":"10.1016\/j.jconrel.2025.113984_bb0060","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcis.2024.09.100","article-title":"Galloyl-boosted gold nanorods: unleashing personalized cancer immunotherapy potential","volume":"678","author":"Ye","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2023.01.076","article-title":"Photothermal-triggered dendrimer nanovaccines boost systemic antitumor immunity","volume":"355","author":"Shen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113984_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg3551","article-title":"Tumor-draining lymph nodes: at the crossroads of metastasis and immunity","volume":"6","author":"du Bois","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0075","doi-asserted-by":"crossref","unstructured":"X. Li, Y. Zhang, X. Wu, J. Chen, M. Yang, F. Ma, L. Shi, In situ antigen-capturing nanochaperone toward personalized nanovaccine for cancer immunotherapy, Small, 18 (2022) 2203100.","DOI":"10.1002\/smll.202203100"},{"key":"10.1016\/j.jconrel.2025.113984_bb0080","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jconrel.2025.01.087","article-title":"An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy","volume":"379","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113984_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1423212","article-title":"Current status and future directions of nanovaccine for cancer: a bibliometric analysis during 2004-2023","volume":"15","author":"Hou","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111201","article-title":"Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment","volume":"40","author":"Papadas","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.113984_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.2007.00552.x","article-title":"Phagocytosis and antigen presentation in dendritic cells","volume":"219","author":"Savina","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0100","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1084\/jem.190.10.1417","article-title":"In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas","volume":"190","author":"Bell","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb0105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1146\/annurev.immunol.22.012703.104538","article-title":"Cell biology of antigen processing in vitro and in vivo","volume":"23","author":"Trombetta","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0110","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.biomaterials.2013.10.003","article-title":"Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response","volume":"35","author":"Thomas","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113984_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00018-024-05191-6","article-title":"cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41577-024-01079-5","article-title":"Striking a balance: new perspectives on homeostatic dendritic cell maturation","volume":"25","author":"Bosteels","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.immunol.19.1.47","article-title":"Cross-presentation, dendritic cells, tolerance and immunity","volume":"19","author":"Heath","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0130","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103+\/CD141+ dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.113984_bb0135","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1038\/s41467-024-52577-y","article-title":"Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113984_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4+ T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0150","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2025.113984_bb0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.1258867","article-title":"A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection","volume":"348","author":"Deng","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.113984_bb0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.coi.2010.02.006","article-title":"Natural immunity to cancer in humans","volume":"22","author":"Bindea","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0165","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fimmu.2013.00438","article-title":"Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity","volume":"4","author":"Dudek","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0170","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113984_bb0175","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.immuni.2017.01.005","article-title":"A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells","volume":"46","author":"Mondanelli","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.113984_bb0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1074-7613(03)00171-7","article-title":"TNF\/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection","volume":"19","author":"Serbina","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.113984_bb0190","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.4049\/jimmunol.1200819","article-title":"Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO","volume":"189","author":"Sumpter","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0195","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nri1685","article-title":"Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors","volume":"5","author":"Sitkovsky","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613492","article-title":"Metabolism of dendritic cells in tumor microenvironment: for immunotherapy","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0205","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.immuni.2023.05.011","article-title":"Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses","volume":"56","author":"Bayerl","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.113984_bb0210","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4049\/jimmunol.179.3.1497","article-title":"Prostaglandin E2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva","volume":"179","author":"S\u00e1-Nunes","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0215","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1096-1096","article-title":"Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells","volume":"2","author":"Gabrilovich","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb0220","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221757","article-title":"IL-6 selectively suppresses cDC1 specification via C\/EBP\u03b2","volume":"220","author":"Kim","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1471-4906(03)00111-X","article-title":"What\u2019s the difference between CD80 and CD86?","volume":"24","author":"Sansom","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0230","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2249.1998.00713.x","article-title":"IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules","volume":"114","author":"Knolle","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0235","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.113984_bb0240","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41388-020-1216-5","article-title":"The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment","volume":"39","author":"Brown","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2025.113984_bb0245","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3389\/fimmu.2019.01878","article-title":"Lactate induces pro-tumor reprogramming in intratumoral plasmacytoid dendritic cells","volume":"10","author":"Raychaudhuri","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0250","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cmet.2020.03.001","article-title":"Why Warburg works: lactate controls immune evasion through GPR81","volume":"31","author":"Lund\u00f8","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2025.113984_bb0255","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1158\/0008-5472.CAN-17-1307","article-title":"Downregulation of membrane trafficking proteins and lactate conditioning determine loss of dendritic cell function in lung cancer","volume":"78","author":"Caronni","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113984_bb0260","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12967-022-03714-y","article-title":"Whole-cell tumor vaccines desialylated to uncover tumor antigenic gal\/GalNAc epitopes elicit anti-tumor immunity","volume":"20","author":"Huang","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb0265","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1021\/jacs.2c12843","article-title":"MUC1 Glycopeptide vaccine modified with a GalNAc glycocluster targets the macrophage galactose C-type lectin on dendritic cells to elicit an improved humoral response","volume":"145","author":"Gabba","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.113984_bb0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10719-016-9755-2","article-title":"Glycosylation: a hallmark of cancer?","volume":"34","author":"Vajaria","year":"2017","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jconrel.2025.113984_bb0275","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108130","article-title":"ATP and cancer immunosurveillance","volume":"40","author":"Kepp","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2025.113984_bb0280","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2013.03.003","article-title":"Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells","volume":"38","author":"Ma","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.113984_bb0285","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Michaud","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.113984_bb0290","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2016-08-731737","article-title":"Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients","volume":"128","author":"Fucikova","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.113984_bb0295","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2010.82","article-title":"Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia","volume":"1","author":"Wemeau","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2025.113984_bb0300","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2020.12.023","article-title":"Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance","volume":"39","author":"Lin","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.113984_bb0305","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1158\/2159-8290.CD-20-0402","article-title":"Pharmacologic suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers","volume":"10","author":"Song","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.113984_bb0310","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.molcel.2019.11.004","article-title":"Immunosuppression by mutated Calreticulin released from malignant cells","volume":"77","author":"Liu","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2025.113984_bb0315","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41580-023-00674-z","article-title":"Activation of human endogenous retroviruses and its physiological consequences","volume":"25","author":"Dopkins","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0320","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","article-title":"Cancer stem cell mimicry for immune evasion and therapeutic resistance","volume":"31","author":"Saw","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jconrel.2025.113984_bb0325","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1189\/jlb.0307166","article-title":"Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells","volume":"82","author":"Cools","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0330","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2018.08.007","article-title":"A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity","volume":"95","author":"Kumar","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2025.113984_bb0340","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221757","article-title":"IL-6 selectively suppresses cDC1 specification via C\/EBPbeta","volume":"220","author":"Kim","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb0345","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ccell.2019.05.005","article-title":"Targeting tumors with IL-10 prevents dendritic cell-mediated CD8+ T cell apoptosis","volume":"35","author":"Qiao","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.113984_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190333","article-title":"Dysregulation in IFN-\u03b3 signaling and response: the barricade to tumor immunotherapy","volume":"14","author":"Han","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0355","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2019.06.014","article-title":"Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold","volume":"178","author":"Vredevoogd","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.113984_bb0360","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/physrev.00023.2001","article-title":"Dendritic cells: immune regulators in health and disease","volume":"82","author":"Lipscomb","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113984_bb0370","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.113984_bb0375","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1039\/D2MH01358D","article-title":"Polymeric nanoparticle-based nanovaccines for cancer immunotherapy","volume":"10","author":"Zhang","year":"2023","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.jconrel.2025.113984_bb0380","first-page":"169","article-title":"Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapy","volume":"26","author":"Su","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0385","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1021\/acsnano.3c13038","article-title":"Antigen-clustered nanovaccine achieves long-term tumor remission by promoting B\/CD 4 T cell crosstalk","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb0390","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1021\/mp400717r","article-title":"Tracking targeted bimodal nanovaccines: immune responses and routing in cells, tissue, and whole organism","volume":"11","author":"Cruz","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.113984_bb0395","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113984_bb0400","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","article-title":"Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment","volume":"18","author":"Myers","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0405","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41467-023-37369-0","article-title":"Bacterial outer membrane vesicle based versatile nanosystem boosts the efferocytosis blockade triggered tumor-specific immunity","volume":"14","author":"Zhuang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113984_bb0410","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.molimm.2008.10.020","article-title":"Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines","volume":"46","author":"Kafi","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0415","article-title":"Programmed catalytic therapy and antigen capture-mediated dendritic cells harnessing cancer immunotherapies by in situ-forming adhesive nanoreservoirs","volume":"33","author":"Yalamandala","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0420","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2025.113984_bb0425","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jconrel.2025.113984_bb0430","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/sj.cdd.4402201","article-title":"Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis","volume":"14","author":"Obeid","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2025.113984_bb0435","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb0440","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113984_bb0445","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-018-0360-8","article-title":"Targeting adenosine for cancer immunotherapy","volume":"6","author":"Leone","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0450","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.2007.00573.x","article-title":"The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy","volume":"220","author":"Apetoh","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0455","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1479-5876-12-211","article-title":"TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant","volume":"12","author":"Saenz","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb0460","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/02656730902835672","article-title":"Hyperthermia classic commentary: activation of natural killer (NK) cells by heat shock protein 70, Gabriele Multhoff, international journal of hyperthermia, 2002;18:576-585","volume":"25","author":"Multhoff","year":"2009","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.jconrel.2025.113984_bb0465","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","article-title":"The mechanism of HMGB1 secretion and release","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb0470","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102335","article-title":"Cationic lipid-polymer hybrid nanoparticle drives in situ generation and lymphatic navigation of tumor antigens to prime systemic antitumor immunity","volume":"57","author":"Chen","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.113984_bb0480","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.113984_bb0485","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/MO:18:4:243","article-title":"Treatment resistance of solid tumors: role of hypoxia and anemia","volume":"18","author":"Vaupel","year":"2001","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120974","article-title":"Convection enhanced delivery of light responsive antigen capturing oxygen generators for chemo-phototherapy triggered adaptive immunity","volume":"275","author":"Sunil","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113984_bb0495","doi-asserted-by":"crossref","first-page":"18376","DOI":"10.1021\/acsnano.2c06356","article-title":"Decrease in tumor interstitial pressure for enhanced drug Intratumoral delivery and synergistic tumor therapy","volume":"16","author":"Fu","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb0500","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb0505","doi-asserted-by":"crossref","first-page":"18604","DOI":"10.1021\/acsnano.4c04766","article-title":"Multifunctional nanoparticle-loaded injectable alginate hydrogels with deep tumor penetration for enhanced chemo-immunotherapy of cancer","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb0510","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s40425-019-0698-6","article-title":"Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition","volume":"7","author":"Newton","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0515","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201870173","article-title":"Personalized cancer immunotherapy via transporting endogenous tumor antigens to lymph nodes mediated by nano Fe3 O4","volume":"14","author":"Wang","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.113984_bb0520","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202000335","article-title":"Near-infrared triggered cascade of antitumor immune responses based on the integrated core\u2013shell nanoparticle","volume":"30","author":"Cheng","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0525","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1039\/D4CS00421C","article-title":"Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond","volume":"53","author":"Hsu","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0530","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113984_bb0535","first-page":"57","article-title":"Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation","volume":"21","author":"Xiao","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0540","doi-asserted-by":"crossref","first-page":"14475","DOI":"10.1021\/acsnano.3c00901","article-title":"Ferroptosis and necroptosis produced autologous tumor cell lysates co-delivering with combined Immnoadjuvants as personalized in situ nanovaccines for antitumor immunity","volume":"17","author":"Shi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb0545","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0550","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101496","article-title":"Near-infrared responsive membrane Nanovesicles amplify homologous targeting delivery of anti-PD immunotherapy against metastatic tumors","volume":"11","author":"Tan","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0555","article-title":"Supramolecular assembled programmable nanomedicine as in situ cancer vaccine for cancer immunotherapy","volume":"33","author":"Zhang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0560","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41563-018-0093-6","article-title":"Dendritic cells in cancer immunotherapy","volume":"17","author":"Le Gall","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0565","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.str.2017.11.006","article-title":"Structural insights into the pH-dependent conformational change and collagen recognition of the human mannose receptor","volume":"26","author":"Hu","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.jconrel.2025.113984_bb0570","doi-asserted-by":"crossref","first-page":"25826","DOI":"10.1021\/acsnano.4c09053","article-title":"Glucosylated nanovaccines for dendritic cell-targeted antigen delivery and amplified cancer immunotherapy","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb0575","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0580","doi-asserted-by":"crossref","first-page":"13278","DOI":"10.1021\/acsnano.3c00941","article-title":"Liquid metal nanoplatform based autologous cancer vaccines","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb0585","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12943-024-02130-8","article-title":"Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0590","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0595","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113984_bb0600","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.ai.2016.01.001","article-title":"The role of neoantigens in naturally occurring and therapeutically induced immune responses to cancer","volume":"130","author":"Ward","year":"2016","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0605","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2867-5-4","article-title":"Cancer\/testis antigens and gametogenesis: a review and \u201cbrain-storming\u201d session","volume":"5","author":"Kalejs","year":"2005","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2025.113984_bb0610","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0615","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-immunol-042617-053402","article-title":"Cancer neoantigens","volume":"37","author":"Schumacher","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0620","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13045-019-0787-5","article-title":"Tumor neoantigens: from basic research to clinical applications","volume":"12","author":"Jiang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0625","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4049\/jimmunol.1701413","article-title":"Hitting the target: how T cells detect and eliminate tumors","volume":"200","author":"Zamora","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0630","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1039\/D3CS00162H","article-title":"Advancing nanotechnology for neoantigen-based cancer theranostics","volume":"53","author":"Zou","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0635","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2022.10.013","article-title":"Challenges in neoantigen-directed therapeutics","volume":"41","author":"Lybaert","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.113984_bb0640","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-20-1575","article-title":"Exploiting tumor neoantigens to target cancer evolution: current challenges and promising therapeutic approaches","volume":"11","author":"Gupta","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.113984_bb0645","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.apsb.2022.02.026","article-title":"Hyperthermia based individual in situ recombinant vaccine enhances lymph nodes drainage for de novo antitumor immunity","volume":"12","author":"Zheng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.113984_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201902626","article-title":"Development of an in situ cancer vaccine via combinational radiation and bacterial-membrane-coated nanoparticles","volume":"31","author":"Patel","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0655","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrd.2015.6","article-title":"Regulated necrosis: disease relevance and therapeutic opportunities","volume":"15","author":"Conrad","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113984_bb0660","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.113984_bb0665","doi-asserted-by":"crossref","first-page":"20142","DOI":"10.1021\/acsnano.4c02206","article-title":"S-Sulfenylation driven antigen capture boosted by radiation for enhanced cancer immunotherapy","volume":"18","author":"Zhu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb0670","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1158\/0008-5472.CAN-10-1825","article-title":"Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death","volume":"70","author":"Zappasodi","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113984_bb0675","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/ijc.28515","article-title":"Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells","volume":"134","author":"Paroli","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0680","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12951-024-02744-6","article-title":"Tumor targeting peptide TMTP1 modified antigen capture nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer","volume":"22","author":"Zhou","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0685","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1080\/10408398.2024.2315473","article-title":"A breakthrough of immunoassay format for hapten: recent insights into noncompetitive immunoassays to detect small molecules","volume":"65","author":"Liang","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jconrel.2025.113984_bb0690","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1038\/s41467-025-59840-w","article-title":"Integrating antigen capturing nanoparticles and type 1 conventional dendritic cell therapy for in situ cancer immunization","volume":"16","author":"Chao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113984_bb0695","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/vaccines9060563","article-title":"Chemical conjugation strategies for the development of protein-based subunit nanovaccines","volume":"9","author":"Lu","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2025.113984_bb0700","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41570-019-0095-1","article-title":"Molecular conjugation using non-covalent click chemistry","volume":"3","author":"Schreiber","year":"2019","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.jconrel.2025.113984_bb0705","first-page":"1","article-title":"The non-covalent and covalent interactions of whey proteins and saccharides: influencing factor and utilization in food","author":"Zhang","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jconrel.2025.113984_bb0710","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.chemrev.7b00305","article-title":"Electrostatic interactions in protein structure, folding, binding, and condensation","volume":"118","author":"Zhou","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0715","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1038\/s41467-023-41866-7","article-title":"Counteranion-mediated efficient iodine capture in a hexacationic imidazolium organic cage enabled by multiple non-covalent interactions","volume":"14","author":"Yang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113984_bb0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.progpolymsci.2017.04.001","article-title":"Bioinspired fabrication of high strength hydrogels from non-covalent interactions","volume":"71","author":"Wang","year":"2017","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb0725","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/wcms.8","article-title":"Noncovalent interactions in biochemistry","volume":"1","author":"Riley","year":"2011","journal-title":"WIREs Computational Molecular Science"},{"key":"10.1016\/j.jconrel.2025.113984_bb0730","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1021\/cr990061j","article-title":"Weakly bound clusters of biological interest","volume":"100","author":"Desfran\u00e7ois","year":"2000","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0735","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1021\/cr500344e","article-title":"Cooperativity in noncovalent interactions","volume":"116","author":"Mahadevi","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0740","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00216-011-5593-z","article-title":"Computational analysis of non-covalent polymer-protein interactions governing antibody orientation","volume":"402","author":"Farris","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jconrel.2025.113984_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108856","article-title":"A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding","volume":"34","author":"Akbar","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.113984_bb0750","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305356","article-title":"Control of properties through hydrogen bonding interactions in conjugated polymers","volume":"11","author":"Wan","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb0755","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1021\/acs.jcim.1c00167","article-title":"Analysis of binding modes of antigen-antibody complexes by molecular mechanics calculation","volume":"61","author":"Qu","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jconrel.2025.113984_bb0760","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb2712","article-title":"AIEgen-coupled upconversion nanoparticles eradicate solid tumors through dual-mode ROS activation","volume":"6","author":"Mao","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.113984_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120921","article-title":"PolyTLR7\/8a-conjugated, antigen-trapping gold nanorods elicit anticancer immunity against abscopal tumors by photothermal therapy-induced in situ vaccination","volume":"275","author":"Liu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113984_bb0770","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/antib8040055","article-title":"Antibody structure and function: the basis for engineering therapeutics","volume":"8","author":"Chiu","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.jconrel.2025.113984_bb0775","first-page":"155","article-title":"Affinity and avidity in antibody-based tumor targeting","volume":"24","author":"Rudnick","year":"2009","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.jconrel.2025.113984_bb0780","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad392","article-title":"Understanding the complementarity and plasticity of antibody-antigen interfaces","volume":"39","author":"Myung","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jconrel.2025.113984_bb0785","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1038\/s41598-019-40461-5","article-title":"Exploring designability of electrostatic complementarity at an antigen-antibody interface directed by mutagenesis, biophysical analysis, and molecular dynamics simulations","volume":"9","author":"Yoshida","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113984_bb0790","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/prot.24527","article-title":"Cation-\u03c0, amino-\u03c0, \u03c0-\u03c0, and H-bond interactions stabilize antigen-antibody interfaces","volume":"82","author":"Dalkas","year":"2014","journal-title":"Proteins"},{"key":"10.1016\/j.jconrel.2025.113984_bb0795","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1038\/s41467-023-40821-w","article-title":"Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen","volume":"14","author":"Wright","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113984_bb0800","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.1241145","article-title":"Antibody therapeutics in cancer","volume":"341","author":"Sliwkowski","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.113984_bb0805","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/2326-6066.CIR-18-0266","article-title":"A mechanism of resistance to antibody-targeted immune attack","volume":"7","author":"Aldeghaither","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.113984_bb0810","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrd3003","article-title":"The safety and side effects of monoclonal antibodies","volume":"9","author":"Hansel","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113984_bb0815","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb0820","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nbt.1691","article-title":"Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization","volume":"28","author":"Igawa","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0825","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jps.23645","article-title":"Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment","volume":"102","author":"Wang","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb0830","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1038\/s41467-024-50316-x","article-title":"Temperature sensitivity of bat antibodies links metabolic state of bats with antigen-recognition diversity","volume":"15","author":"Toshkova","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113984_bb0835","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1039\/D4NA00032C","article-title":"Boosted photo-immunotherapy via near-infrared light excited phototherapy in tumor sites and photo-activation in sentinel lymph nodes","volume":"6","author":"Wang","year":"2024","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.jconrel.2025.113984_bb0840","doi-asserted-by":"crossref","first-page":"12390","DOI":"10.1021\/jacs.2c03959","article-title":"Transformation of porous organic cages and covalent organic frameworks with efficient iodine vapor capture performance","volume":"144","author":"Liu","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.113984_bb0845","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.scib.2022.02.012","article-title":"Pyridinium salt-based covalent organic framework with well-defined nanochannels for efficient and selective capture of aqueous 99TcO4","volume":"67","author":"Hao","year":"2022","journal-title":"Sci. Bull."},{"key":"10.1016\/j.jconrel.2025.113984_bb0850","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1021\/acs.jpca.2c03221","article-title":"Demarcating noncovalent and covalent bond territories: imine-CO2 complexes and cooperative CO2 capture","volume":"126","author":"Anila","year":"2022","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.jconrel.2025.113984_bb0855","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1021\/acs.chemrev.4c00066","article-title":"Biospecific chemistry for covalent linking of biomacromolecules","volume":"124","author":"Cao","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0860","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1021\/acs.chemrev.0c01282","article-title":"Clip chemistry: diverse (bio)(macro)molecular and material function through breaking covalent bonds","volume":"121","author":"Shieh","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0865","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1021\/acs.jmedchem.0c00754","article-title":"The Most common functional groups in bioactive molecules and how their popularity has evolved over time","volume":"63","author":"Ertl","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.113984_bb0870","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nmat2069","article-title":"Transition metal oxides: the exciting world of orbitals","volume":"6","author":"Cheong","year":"2007","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0875","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.283.5408.1727","article-title":"How strong is a covalent bond?","volume":"283","author":"Grandbois","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.113984_bb0880","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1039\/C7CS00220C","article-title":"Structure-based design of targeted covalent inhibitors","volume":"47","author":"Lonsdale","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0885","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1021\/acs.jmedchem.1c01719","article-title":"Discovery of cysteine-targeting covalent protein kinase inhibitors","volume":"65","author":"Lu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.113984_bb0890","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1021\/cr300163e","article-title":"Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery","volume":"113","author":"Paulsen","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0895","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.progpolymsci.2006.03.001","article-title":"Michael addition reactions in macromolecular design for emerging technologies","volume":"31","author":"Mather","year":"2006","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb0900","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1021\/jacs.7b00513","article-title":"Designing peptide and protein modified hydrogels: selecting the optimal conjugation strategy","volume":"139","author":"Fisher","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.113984_bb0905","doi-asserted-by":"crossref","first-page":"13964","DOI":"10.1021\/acsami.9b01107","article-title":"Surface-functionalized modified copper sulfide nanoparticles enhance checkpoint blockade tumor immunotherapy by Photothermal therapy and antigen capturing","volume":"11","author":"Wang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113984_bb0910","first-page":"389","article-title":"Synergistic enhancement of immunological responses triggered by hyperthermia sensitive Pt NPs via NIR laser to inhibit cancer relapse and metastasis","volume":"7","author":"Yu","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.127355","article-title":"Covalent conjugation with (\u2212)-epigallo-catechin 3-gallate and chlorogenic acid changes allergenicity and functional properties of Ara h1 from peanut","volume":"331","author":"He","year":"2020","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2025.113984_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2024.141669","article-title":"Antigenicity elimination of ovalbumin by cold plasma-induced covalent binding with Gallic acid","volume":"464","author":"Liu","year":"2025","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2025.113984_bb0925","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/imr.13377","article-title":"Antibody feedback regulation","volume":"328","author":"Heyman","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0930","first-page":"99","article-title":"Epitope masking of rat esophageal carcinoma tumor-associated antigen by certain coexisting glycolipid and phospholipid molecules: a potential mechanism for tumor cell escape from the host immune responses","volume":"38","author":"Jamasbi","year":"1994","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2025.113984_bb0935","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.3168\/jds.2014-9010","article-title":"Conformational changes of \u03b2-lactoglobulin induced by shear, heat, and pH-effects on antigenicity","volume":"98","author":"Rahaman","year":"2015","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb0940","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1080\/10408398.2022.2078273","article-title":"A review on polyphenols and their potential application to reduce food allergenicity","volume":"63","author":"Pi","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jconrel.2025.113984_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.134820","article-title":"Protein modification, IgE binding capacity, and functional properties of soybean protein upon conjugation with polyphenols","volume":"405","author":"Pi","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2025.113984_bb0950","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1039\/C3CS60342C","article-title":"Functional systems with orthogonal dynamic covalent bonds","volume":"43","author":"Wilson","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0955","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1016\/S0021-9258(19)89185-8","article-title":"The reaction of ribosomes with elongation factor Tu.GTP complexes. Aminoacyl-tRNA-independent reactions in the elongation cycle determine the accuracy of protein synthesis","volume":"261","author":"Thompson","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.113984_bb0960","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1002\/anie.200803583","article-title":"Covalent capture: merging covalent and noncovalent synthesis","volume":"48","author":"Prins","year":"2009","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2025.113984_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202010587","article-title":"Injectable adhesive hydrogel as photothermal-derived antigen reservoir for enhanced anti-tumor immunity","volume":"31","author":"Fan","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb0970","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/anie.201801063","article-title":"The chemistry behind catechol-based adhesion","volume":"58","author":"Saiz-Poseu","year":"2019","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2025.113984_bb0975","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1039\/C4CS00185K","article-title":"Jack of all trades: versatile catechol crosslinking mechanisms","volume":"43","author":"Yang","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb0980","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15171\/apb.2017.002","article-title":"Application of various types of liposomes in drug delivery systems","volume":"7","author":"Alavi","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2025.113984_bb0985","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113984_bb0990","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1080\/21691401.2017.1290647","article-title":"Liposome-targeted delivery for highly potent drugs","volume":"45","author":"Bardania","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb0995","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/14760584.2023.2274479","article-title":"Vaccine approaches for antigen capture by liposomes","volume":"22","author":"Zhou","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2025.113984_bb1000","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijpharm.2012.06.056","article-title":"The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs","volume":"453","author":"Ali","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113984_bb1005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2019.05.030","article-title":"Liposome and immune system interplay: challenges and potentials","volume":"305","author":"Zahednezhad","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113984_bb1010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0169-409X(99)00041-1","article-title":"The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs","volume":"40","author":"Nagayasu","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb1015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2016.02.018","article-title":"Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: a comparative study of cationic liposomes and PLGA nanoparticles","volume":"226","author":"Varypataki","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113984_bb1020","first-page":"487","article-title":"Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages","volume":"41","author":"Raz","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113984_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104143","article-title":"Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity","volume":"354","author":"Mai","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.canlet.2021.09.031","article-title":"Thermal-sensitive lipid nanoparticles potentiate anti-PD therapy through enhancing drug penetration and T lymphocytes infiltration in metastatic tumor","volume":"522","author":"Tan","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.113984_bb1035","article-title":"Stapled liposomes enhance cross-priming of radio-immunotherapy","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.actbio.2021.09.052","article-title":"A combination strategy based on an au nanorod\/doxorubicin gel via mild photothermal therapy combined with antigen-capturing liposomes and anti-PD-L1 agent promote a positive shift in the cancer-immunity cycle","volume":"136","author":"Feng","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1045","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3390\/pharmaceutics14112279","article-title":"Enhancing the efficiency of mild-temperature photothermal therapy for cancer assisting with various strategies","volume":"14","author":"Wang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113984_bb1050","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113984_bb1055","first-page":"1191","article-title":"A SARS-CoV-2 mRNA vaccine - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"Reply N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115190","article-title":"Schiffelers, mRNA delivery systems for cancer immunotherapy: lipid nanoparticles and beyond","volume":"206","author":"Estap\u00e9 Senti","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb1065","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002022","article-title":"Therapeutic RNA delivery for COVID and other diseases","volume":"10","author":"Dobrowolski","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb1075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb1080","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202404830","article-title":"pH-responsive \u03b2-glucans-complexed mRNA in LNPs as an Oral vaccine for enhancing Cancer immunotherapy","volume":"36","author":"Luo","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1085","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jconrel.2024.03.016","article-title":"Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy","volume":"368","author":"Jiang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113984_bb1090","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202470228","article-title":"Tumor-tailored ionizable lipid nanoparticles facilitate IL-12 circular RNA delivery for enhanced lung cancer immunotherapy","volume":"36","author":"Xu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1095","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1038\/s41598-019-39107-3","article-title":"Polymeric engineering of nanoparticles for highly efficient multifunctional drug delivery systems","volume":"9","author":"Fortuni","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113984_bb1100","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1039\/C5BM00006H","article-title":"Shape control in engineering of polymeric nanoparticles for therapeutic delivery","volume":"3","author":"Williford","year":"2015","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb1105","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202401631","article-title":"Cancer Nanovaccines: nanomaterials and clinical perspectives","volume":"20","author":"Desai","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.113984_bb1110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12951-021-00896-3","article-title":"Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles","volume":"19","author":"Kianfar","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1115","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1039\/D1TB00628B","article-title":"Polysaccharide nanoparticles: from fabrication to applications","volume":"9","author":"Plucinski","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2025.113984_bb1120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41392-021-00727-9","article-title":"The biological applications of DNA nanomaterials: current challenges and future directions","volume":"6","author":"Ma","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113984_bb1125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.progpolymsci.2018.07.005","article-title":"Pharmapolymers in the 21st century: synthetic polymers in drug delivery applications","volume":"87","author":"Englert","year":"2018","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb1130","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nnano.2017.113","article-title":"Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy","volume":"12","author":"Min","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1135","article-title":"Controlled refolding of denatured IL-12 using in situ antigen-capturing nanochaperone remarkably reduces the systemic toxicity and enhances cancer immunotherapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1140","article-title":"DNA-capturing manganese-coordinated chitosan microparticles potentiate radiotherapy via activating the cGAS-STING pathway and maintaining tumor-infiltrating CD8+ T-cell stemness","volume":"37","author":"Zhang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116126","article-title":"Chitosan-based colloidal polyelectrolyte complexes for drug delivery: a review","volume":"238","author":"Wu","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2025.113984_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116270","article-title":"Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy","volume":"240","author":"Yang","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2025.113984_bb1160","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/adma.200801478","article-title":"Polymeric materials for gene delivery and DNA vaccination","volume":"21","author":"Nguyen","year":"2009","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1165","article-title":"Nanochitin and nanochitosan: chitin nanostructure engineering with multiscale properties for biomedical and environmental applications","volume":"35","author":"Lee","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1170","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aag1266","article-title":"The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications","volume":"1","author":"Spiotto","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1175","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1870","article-title":"Instigation of the epoch of nanovaccines in cancer immunotherapy","volume":"15","author":"Shah","year":"2023","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1180","doi-asserted-by":"crossref","DOI":"10.26599\/NTM.2023.9130019","article-title":"Nanodiamond in cancer theranostics","volume":"2","author":"Li","year":"2023","journal-title":"Nano TransMed."},{"key":"10.1016\/j.jconrel.2025.113984_bb1185","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.3390\/pharmaceutics13111811","article-title":"Antigen-capturing mesoporous silica nanoparticles enhance the radiation-induced abscopal effect in murine hepatocellular carcinoma Hepa1-6 models","volume":"13","author":"Yang","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113984_bb1190","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202407199","article-title":"An acceptor-donor-acceptor structured nano-aggregate for NIR-triggered interventional photoimmunotherapy of cervical cancer","volume":"36","author":"Niu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s40820-023-01193-4","article-title":"Artificial macrophage with hierarchical nanostructure for biomimetic reconstruction of antitumor immunity","volume":"15","author":"Zhao","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.113984_bb1200","article-title":"Boosting antitumor immunity via a tumor microenvironment-responsive transformable trifecta nanovaccine","volume":"34","author":"Li","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1205","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2019.100795","article-title":"Nanoparticles-based magnetic and photo induced hyperthermia for cancer treatment","volume":"29","author":"Sharma","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.113984_bb1210","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.2147\/IJN.S269321","article-title":"Pathological mechanism of photodynamic therapy and photothermal therapy based on nanoparticles","volume":"15","author":"Hou","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113984_bb1215","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/pharmaceutics15051346","article-title":"Prospects for the use of metal-based nanoparticles as adjuvants for local cancer immunotherapy","volume":"15","author":"Naletova","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113984_bb1220","article-title":"Biomedical applications of mesoporous silica nanoparticles as a drug delivery carrier","volume":"76","author":"Ahmed","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1225","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1039\/D1CS00659B","article-title":"Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?","volume":"51","author":"Vallet-Regi","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb1230","article-title":"Elastic nanovaccine enhances dendritic cell-mediated tumor immunotherapy","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.113984_bb1235","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202100106","article-title":"Engineering the deformability of albumin-stabilized emulsions for lymph-node vaccine delivery","volume":"33","author":"Song","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1240","article-title":"Bioinspired and biomimetic delivery platforms for cancer vaccines","volume":"34","author":"Liu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1245","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1039\/D0CS00152J","article-title":"Cell primitive-based biomimetic functional materials for enhanced cancer therapy","volume":"50","author":"Luo","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb1250","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.tibtech.2015.07.001","article-title":"Biomimetic particles as therapeutics","volume":"33","author":"Meyer","year":"2015","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.smim.2017.09.011","article-title":"Effects of engineered nanoparticles on the innate immune system","volume":"34","author":"Liu","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1260","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41551-021-00834-6","article-title":"Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria","volume":"6","author":"Wang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.113984_bb1265","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202370416","article-title":"Engineered extracellular vesicles to enhance antigen presentation for boosting light-driven tumor immunotherapy","volume":"19","author":"Li","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.113984_bb1270","doi-asserted-by":"crossref","first-page":"24947","DOI":"10.1021\/acsnano.3c06784","article-title":"Dendritic cell-based in situ nanovaccine for reprogramming lipid metabolism to boost tumor immunotherapy","volume":"17","author":"Qin","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb1275","first-page":"347","article-title":"Characterization of structure and direct antigen presentation by dendritic\/tumor-fused cells as cancer vaccines","volume":"33","author":"Koido","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2025.113984_bb1280","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood-2003-08-2820","article-title":"Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production","volume":"104","author":"Chalifour","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.113984_bb1285","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121124","article-title":"Bacterial-based cancer therapy: an emerging toolbox for targeted drug\/gene delivery","volume":"277","author":"Lin","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113984_bb1290","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101537","article-title":"Multimodal oncolytic bacteria by coating with tumor cell derived nanoshells","volume":"45","author":"Liu","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.113984_bb1295","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Thery","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1300","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201054","article-title":"Extracellular-vesicle-based drug delivery systems for enhanced antitumor therapies through modulating the cancer-immunity cycle","volume":"34","author":"Yong","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.plipres.2015.04.003","article-title":"Membrane lipid therapy: modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment","volume":"59","author":"Escriba","year":"2015","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jconrel.2025.113984_bb1310","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1315","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nri.2017.25","article-title":"Multi-receptor detection of individual bacterial products by the innate immune system","volume":"17","author":"Kieser","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101007","article-title":"Nanovaccines integrating endogenous antigens and pathogenic adjuvants elicit potent antitumor immunity","volume":"35","author":"Li","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.113984_bb1325","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm0597-558","article-title":"Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells","volume":"3","author":"Gong","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb1330","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.4049\/jimmunol.168.5.2111","article-title":"The kinetics of in vivo priming of CD4 and CD8 T cells by dendritic\/tumor fusion cells in MUC1-transgenic mice","volume":"168","author":"Koido","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1335","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113984_bb1340","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jamaoncol.2016.2064","article-title":"Oncolytic viruses in cancer treatment: a review","volume":"3","author":"Lawler","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1345","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001486","article-title":"Clinical landscape of oncolytic virus research in 2020","volume":"8","author":"Macedo","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb1350","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.3390\/ijms22105240","article-title":"Adenovirus structure: what is new?","volume":"22","author":"Gallardo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb1355","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101922","article-title":"Antigen-capturing oncolytic adenoviruses along with IDO blockade for improved tumor immunotherapy","volume":"51","author":"Xu","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.113984_bb1360","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb1365","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines-lessons learned from successes and failures","volume":"52","author":"He","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2025.113984_bb1370","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acs.jpclett.1c03898","article-title":"Opportunities and challenges for mRNA delivery nanoplatforms","volume":"13","author":"Zhang","year":"2022","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.jconrel.2025.113984_bb1375","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/all.15187","article-title":"The form of PEG matters: PEG conjugated with lipids and not PEG alone could be the specific form involved in allergic reactions to COVID-19 vaccines","volume":"77","author":"Cabanillas","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.113984_bb1380","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb1385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DDC-120001481","article-title":"Nanoparticle technology for drug delivery across the blood-brain barrier","volume":"28","author":"Lockman","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2025.113984_bb1390","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41565-021-00856-w","article-title":"Molybdenum derived from nanomaterials incorporates into molybdenum enzymes and affects their activities in vivo","volume":"16","author":"Cao","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1395","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1039\/D2CS00352J","article-title":"Bioactive inorganic nanomaterials for cancer theranostics","volume":"52","author":"Pei","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb1400","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401615","article-title":"Harnessing bacterial membrane components for tumor vaccines: strategies and perspectives","volume":"13","author":"Bai","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1405","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300569","article-title":"Immunomodulatory activities and biomedical applications of melittin and its recent advances","volume":"357","author":"Jafari","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.jconrel.2025.113984_bb1410","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2024.08.047","article-title":"Melittin-incorporated nanomedicines for enhanced cancer immunotherapy","volume":"375","author":"Duan","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113984_bb1415","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1039\/D3TB03044J","article-title":"Immunologically effective biomaterials enhance immunotherapy of prostate cancer","volume":"12","author":"Liu","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2025.113984_bb1420","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/anie.201804882","article-title":"Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy","volume":"58","author":"Duan","year":"2019","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2025.113984_bb1425","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1524","article-title":"In situ vaccination: harvesting low hanging fruit on the cancer immunotherapy tree","volume":"11","author":"Sheen","year":"2019","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1430","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-025-01692-4","article-title":"Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy","volume":"18","author":"Liu","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1435","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1440","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119902","article-title":"Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: the current status and transcytosis strategy","volume":"240","author":"Zhou","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113984_bb1445","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2147\/DDDT.S467835","article-title":"Development of intratumoral drug delivery based strategies for antitumor therapy","volume":"18","author":"Jiang","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2025.113984_bb1450","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204335","article-title":"Targeted cancer immunotherapy: nanoformulation engineering and clinical translation","volume":"9","author":"Yu","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113984_bb1455","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113984_bb1460","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.113984_bb1465","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12951-022-01548-w","article-title":"Recent advances in smart nanoplatforms for tumor non-interventional embolization therapy","volume":"20","author":"Dong","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1470","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s41563-021-01047-7","article-title":"Obstacles and opportunities in a forward vision for cancer nanomedicine","volume":"20","author":"de L\u00e1zaro","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2025.113984_bb1475","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1480","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac6522","article-title":"Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle","volume":"7","author":"Miller","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.113984_bb1485","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1158\/0008-5472.CAN-13-3494","article-title":"Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment","volume":"74","author":"Yokoi","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113984_bb1490","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb1495","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41568-018-0104-6","article-title":"Modelling cancer in microfluidic human organs-on-chips","volume":"19","author":"Sontheimer-Phelps","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113984_bb1500","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.06.001","article-title":"Advances on colorectal cancer 3D models: the needed translational technology for nanomedicine screening","volume":"175","author":"Castro","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb1505","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114083","article-title":"Clinical translation of nanomedicines: challenges, opportunities, and keys","volume":"181","author":"Younis","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb1510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-017-0160-y","article-title":"Preservation and storage stability of extracellular vesicles for therapeutic applications","volume":"20","author":"Jeyaram","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2025.113984_bb1515","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","article-title":"Lipid nanoparticles for siRNA delivery in cancer treatment","volume":"361","author":"El Moukhtari","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113984_bb1520","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","volume":"154-155","author":"Shah","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113984_bb1525","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1021\/acsnano.3c02273","article-title":"Stimuli-responsive polymeric nanovaccines toward next-generation immunotherapy","volume":"17","author":"Mao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb1530","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.7150\/thno.112204","article-title":"Inorganic and hybrid nanomaterials for NIR-II fluorescence imaging-guided therapy of glioblastoma and perspectives","volume":"15","author":"Li","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.113984_bb1535","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1021\/nn500299p","article-title":"Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency","volume":"8","author":"Sykes","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb1540","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-8977-7-22","article-title":"Nanomaterial cytotoxicity is composition, size, and cell type dependent","volume":"7","author":"Sohaebuddin","year":"2010","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.jconrel.2025.113984_bb1545","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1021\/acsnano.2c06926","article-title":"Manganese coordination micelles that activate stimulator of interferon genes and capture in situ tumor antigens for cancer metalloimmunotherapy","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113984_bb1550","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay9040","article-title":"Early detection of cancer","volume":"375","author":"Crosby","year":"2022","journal-title":"Science"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:19:01Z","timestamp":1778944741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925006054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":310,"alternative-id":["S0168365925006054"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113984","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ antigen-capture strategies for enhancing dendritic cell-mediated anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113984"}}